Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 31
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

KEY THERAP

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 41
  • 0 comments

FDA approve FENOPROFEN CALCIUM

Comment Full text

AVION PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 36
  • 0 comments

FDA approve MEFENAMIC ACID

Comment Full text

ZYLA LIFE SCIENCES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 38
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

CHARTWELL MOLECULES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 33
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

PFIZER

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 40
  • 0 comments

FDA approve DICLOFENAC SODIUM; MISOPROSTOL

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 37
  • 0 comments

FDA approve ASPIRIN; MEPROBAMATE

Comment Full text

QILU

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 39
  • 0 comments

FDA approve ICOSAPENT ETHYL

Comment Full text

HERITAGE

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 39
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

RISING

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 39
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text
  • Previous
  • 263
  • 264
  • 265
  • 266
  • 267
  • Next

Search

News categories

  • Technical Exchange News(10600)
  • Event(2007)
  • SEC News(184713)
  • FDA Approval(9847)
  • Company Report(721)
  • Business News(122407)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin